VOGT FREDERICK G (Interim CEO & General Counsel) purchased 7.2% of their position (25K shares) of IOVANCE BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $42.3K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/16/2025ACC: 0001104659-25-049999
DirectorOfficer· Interim CEO & General Counsel
Since Mar 2026
+25K
Net shares
Net buyer
$42.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
$1.69
Trade value
$42.25K
% of position
7.2%
5/14/2025
349.65K→374.65K
Total
Net shares
+25K
Net value
$42.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2025 | P · Purchase | +25K | $1.69 | $42.25K | 7.2% | 349.65K | 374.65K |
| Total | +25K | $42.25K | ||||||
Derivative Transactions0
No derivative transactions reported